PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
3.960
-0.010 (-0.25%)
Sep 18, 2026, 4:00 PM EDT - Market closed
PAVmed Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.09 | 0.4 | 39.79 | -64.18 | -88.98 | -50.35 |
Depreciation & Amortization | 0.08 | 0.11 | 1.2 | 2.93 | 2.46 | 0.23 |
Loss (Gain) From Sale of Assets | - | - | -72.29 | -1 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.13 |
Loss (Gain) From Sale of Investments | 2.5 | -8.48 | -0.53 | - | - | - |
Stock-Based Compensation | 4.07 | 2.21 | 7.05 | 11.76 | 19.53 | 15.01 |
Other Operating Activities | -2.58 | 0.46 | -9.28 | -3.15 | -3.28 | -4.05 |
Change in Accounts Receivable | -0.01 | 0 | 0.04 | -0.04 | 0.18 | -0.2 |
Change in Accounts Payable | 0.67 | 0.02 | -0.06 | -0.92 | -0.74 | 0.17 |
Change in Other Net Operating Assets | -0.36 | 0.07 | 0.53 | 2.55 | -0.16 | -1.54 |
Operating Cash Flow | -7.73 | -5.21 | -33.55 | -52.04 | -70.99 | -40.59 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.05 | -0.03 | -0.06 | -0.24 | -1.54 | -1.47 |
Sale of Property, Plant & Equipment | - | - | - | 1 | - | - |
Divestitures | - | - | -16.48 | - | - | - |
Sale (Purchase) of Intangibles | - | - | 0.35 | - | -3.2 | -2.25 |
Investing Cash Flow | -0.05 | -0.03 | -16.18 | 0.76 | -4.74 | -3.72 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 10 | 35.23 | - |
Total Debt Issued | 15 | - | - | 10 | 35.23 | - |
Long-Term Debt Repaid | - | - | -0.53 | -0.08 | - | -14.97 |
Net Debt Issued (Repaid) | 3.85 | - | -0.53 | 9.92 | 35.23 | -14.97 |
Issuance of Common Stock | - | 3.21 | 1.66 | 1.79 | 0.74 | 126.26 |
Repurchase of Common Stock | - | - | - | - | -0.37 | - |
Other Financing Activities | -0 | 2.38 | 30.16 | 19.46 | 2.61 | -6.98 |
Financing Cash Flow | 7.56 | 5.59 | 31.28 | 31.17 | 38.21 | 104.31 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.22 | 0.35 | -18.45 | -20.11 | -37.51 | 60 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.78 | -5.24 | -33.61 | -52.28 | -72.53 | -42.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6948.21% | -7376.06% | -1122.17% | -2132.06% | -19237.40% | -8412.00% |
Free Cash Flow Per Share | -3.28 | -7.81 | -15.46 | -216.88 | -366.39 | -244.17 |
Levered Free Cash Flow | -11.93 | -14 | -20.32 | -27.92 | -39.42 | -22.18 |
Unlevered Free Cash Flow | -11.92 | -13.98 | -20.29 | -27.55 | -38.62 | -22.18 |